Clinical Trials on Liver Cirrhoses in New Zealand

Total 1716 results

Institute of Liver and Biliary Sciences, India

Unknown

"To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR Shunt

Liver Cirrhoses

India
Institute of Liver and Biliary Sciences, India

Recruiting

Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)

Liver Cirrhoses

India
Institute of Liver and Biliary Sciences, India

Completed

Indirect Calorimeter Based Study in Patients With Liver Cirrhosis (METALIC)

Liver Cirrhoses

India
Institute of Liver and Biliary Sciences, India

Unknown

Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.

Liver Cirrhoses

India
Institute of Liver and Biliary Sciences, India

Unknown

Propofol for Sedation of Postoperative Electively Ventilated Liver Transplant Recipients.

Liver Cirrhoses

India
Institute of Liver and Biliary Sciences, India

Completed

N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial

Liver Cirrhoses

India
Institute of Liver and Biliary Sciences, India

Unknown

To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics.

Liver Cirrhoses

India
Institute of Liver and Biliary Sciences, India

Unknown

The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.

Liver Cirrhoses

India
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals Australia Pty Ltd

Completed

Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

United States, Australia, New Zealand
Arena Pharmaceuticals

Terminated

Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Participants With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States, Australia, New Zealand
Institute of Liver and Biliary Sciences, India

Completed

To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.

Cirrhosis, Liver

India
Danny Lascano

Completed

Cirrhotics Undergoing General Surgery

Cirrhosis, Liver

United States
Kirby Institute
University of Public Health, Myanmar

Completed

Simplified Monitoring Myanmar SM2 Study (SM2)

HIV Infections | Hepatitis C | Liver Cirrhoses | Liver Inflammation

Australia
Institute of Liver and Biliary Sciences, India

Recruiting

Rotational Thromboelastometry Versus Conventional Haemostatic Tests in Children With Decompensated Cirrhosis Undergoing Invasive Procedures.

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Withdrawn

Impact of Acute Decompensation in Patients of Cirrhosis With or Without Prior Decompensation

Acute Decompensation in Liver Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Completed

Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation

Cirrhosis, Liver

India
Gilead Sciences

Completed

Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation

Hepatitis C | Cirrhosis | Portal Hypertension | With or Without Liver Decompensation

United States, Spain, New Zealand, Australia, France
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Incidence & Predictive Factors of Recompensation in Children With Decompensated Cirrhosis as Per the Baveno VII Criteria

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Withdrawn

Efficacy and Safety of Endoscopic Variceal Ligation (EVL) Versus EVL Plus Non-selective B-blockers (NSBB) For Prevention of Variceal Rebleed and Non-bleed Related Complications in Patients With Advanced Cirrhosis

Advanced Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Completed

A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Recruiting

The Natural History and Prognostic Factors of Compensated Cirrhosis.

Compensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Unknown

Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Terminated

To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis

HCV Related Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis

Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Withdrawn

Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.

NASH Related Decompensated Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Completed

Rotational Thromboelastometry Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled Trial

Cirrhosis, Liver

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.

Decompensated Cirrhosis

India
Sir Ganga Ram Hospital

Completed

To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis

Cirrhosis

India
Sir Ganga Ram Hospital

Unknown

Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver Cirrhosis

Cirrhosis

India
Dr. Ashish Kumar

Completed

Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation

Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Recruiting

Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.

Refractory Ascites in Children With Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Rotational Thromboelastometry [ROTEM] vs Thromboelastography [TEG] Guided Blood Component Use in Patients With Cirrhosis of Liver With Non-variceal Bleeding.

Liver Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Completed

Influence of Shunt Occlusion on Organ Functions in Hyperammonemic Patients With Cirrhosis Having Porto-systemic Shunt.

Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Unknown

Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis

Cirrhosis

India
New York Presbyterian Hospital

Unknown

Assessing Cirrhosis Quality of Care While Accounting for Cost

Liver Cirrhosis

United States
Institute of Liver and Biliary Sciences, India

Completed

To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis

Cirrhosis

India
Yale University

Terminated

Cirrhosis Readmission Telehealth Project

Cirrhosis

United States
Institute of Liver and Biliary Sciences, India

Completed

Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.

Liver Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Completed

Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis

Cirrhosis

India
NYU Langone Health

Withdrawn

The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis

Cirrhosis

United States
Institute of Liver and Biliary Sciences, India

Unknown

Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites

Liver Cirrhosis

India
Arrowhead Pharmaceuticals

Completed

Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH

Non-alcoholic Steatohepatitis

New Zealand
Kirby Institute

Recruiting

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs (TOPIC)

Hepatitis C | Liver Cirrhoses | Liver Inflammation

Australia
Institute of Liver and Biliary Sciences, India

Not yet recruiting

To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis

Decompensated Cirrhosis | Compensated Cirrhosis

India
Conatus Pharmaceuticals Inc.

Completed

A Study of IDN-6556 in Subjects With Liver Cirrhosis (LC)

Liver Cirrhosis | Hepatic Cirrhosis

United States
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites

Liver Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Recruiting

Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.

Liver Cirrhosis

India
Institute of Liver and Biliary Sciences, India

Withdrawn

Restrictive Versus Liberal Red Blood Cell Transfusion in Patients of Cirrhosis With Septic Shock

Cirrhosis

India
Yale University
Boehringer Ingelheim

Recruiting

Empagliflozin in Patients With Cirrhosis and Ascites (EMPA Liver)

Liver Failure | Cirrhosis

United States

3

Subscribe